A poptosis plays a key role in the regulation of the immune system. For example, the immune system has evolved selection processes that result in clonal deletion, by apoptosis, of autoreactive B and T lymphocytes during their development in the bone marrow and thymus, respectively. Moreover, apoptosis provides a major molecular mechanism not only for the induction of peripheral tolerance and cytotoxic T cell killing, but also for the termination of normal immune responses (1) (2) (3) . Whereas cells that die from damage typically swell and burst (necrosis), apoptosis is a rigorously controlled and highly ordered process that is characterized by dramatic morphological changes in the cell, including shrinkage, chromatin condensation and cleavage, and disassembly into membrane-enclosed vesicles called apoptotic bodies that are rapidly phagocytosed by neighboring cells to prevent induction of inflammation and autoimmune responses (4, 5) . This systematic disassembly of the apoptotic cell appears generally to be executed by caspases, cysteinyl aspartate-specific proteases, which have recently been identified as mammalian homologues of the cell death protein, CED-3, from the nematode Caenorhabditis elegans (6, 7) . Indeed, molecular studies have shown that overexpression of caspases is sufficient to cause apoptosis, and caspase-deficient mice have reduced levels of apoptosis (8, 9) . However, examples of caspase-independent commitment to cell death can be found in several of the classic models of apoptosis, including glucocorticoid-induced death of thymocytes and lymphoid cells, death of hemopoietic cell lines induced by growth factor withdrawal, and Bax-mediated cell death (10 -12) .
It has recently emerged that mitochondrial function plays a pivotal role in determining cellular commitment to survival or apoptosis (12) (13) (14) . Thus, during apoptotic signaling, mitochondrial changes result in enhanced production of reactive oxygen species (ROS), 3 calcium cycling, and disruption of the inner mitochondrial potential (15) . Collapse of the mitochondrial potential has been thought to represent a point of no return in commiting the cell to apoptosis as the resulting increase in the permeability of the outer mitochondrial membrane leads to the release of caspases and factors that promote activation of effector caspases (cytochrome c) and/or induce apoptosis (apoptosis-inducing factor and a caspaseindependent endonuclease) (16 -21) . Mitochondrial integrity has been proposed to be regulated by pro-and anti-apoptotic members of the Bcl-2 family (18, 22) , as these regulators of cell survival or apoptosis appear to target a number of aspects of mitochondrial function, including mitochondrial permeability and homeostasis of ROS status and calcium cycling.
Cell death receptors such as TNF-R and Fas (also known as CD95 or APO-1) mediate much of the rapid apoptotic cell death required by the immune system (23) . They initiate apoptosis by directly recruiting pro-caspases belonging to the IL-1-converting enzyme-like family, such as caspase-1 or -8, to their accessory death domain-transducing molecules, Fas-associated death domain protein, TNF-R-associated death domain protein, receptor-interacting protein, and RIP-associated ICH-1/CED-3-homologous protein with a death domain to induce proteolytic activation of effector caspases (caspase-3 (CPP32)-like subfamily) that have proved to be important for the execution of the later stages of apoptosis (23) . However, repertoire selection during lymphocyte development is mediated via the Ag receptors (1) (2) (3) 23) . We now show that Ag receptor-driven commitment to apoptosis in the immature B cell lymphoma, WEHI-231, is associated with mitochondrial phospholipase A 2 (PLA 2 ) activation, disruption of mitochondrial potential, and profound depletion of cellular ATP levels, but does not cause release of cytochrome c from mitochondria and is independent of caspase activation. Although mitochondrial potential disruption is uncoupled from caspase activation, activation of proteases such as cathepsins does appear to play a role in the postmitochondrial execution of apoptosis by WEHI-231 immature B cells. The physiological relevance of this novel mechanism of lymphocyte apoptosis to the negative selection of autoreactive B cells is supported by recent studies on germinal center B cells that require cathepsin activity for apoptosis (24) and by caspase-deficient mice that were shown to have no substantial defects in B cell selection and development (8, 9, 25) .
Materials and Methods

Cells, reagents, and Abs
The murine B cell lymphoma, WEHI-231, and the human leukemic T cell line, Jurkat, were cultured in RPMI 1640 medium containing 5% FCS, L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin (100 g/ml) (RPMI 1640 complete) at 37°C in 5% CO 2 . RPMI complete media for WEHI-231 B cells were additionally supplemented with 2-ME (50 M). (25, 35) trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester (EST), antimycin A, and oligomycin were obtained from Calbiochem (Cambridge, MA). Purified anti-IgM mAbs (anti-mouse -chain), anti-CD40, and anti-human CD3 Abs were produced from the B7.6, FGK45, and OKT3 hybridomas, respectively, as described previously (26, 27) . Additional Abs for Western blotting were obtained as follows: anti-cytosolic phospholipase A 2 (cPLA 2 ) (26) and anti-cytochrome c from PharMingen (San Diego, CA) and from Santa Cruz Biotechnology (Santa Cruz, CA), anti-poly(ADP-ribose) polymerase (PARP) from Santa Cruz Biotechnology, and anti-cleaved PARP from New England Biolabs (Hitchin, Herts, U.K.).
DNA synthesis (thymidine uptake)
Exponentially growing cells (10 4 cells/well) in RPMI 1640 complete medium supplemented with 2-ME (50 M), sodium pyruvate (1 mM), and nonessential amino acids (1%) were stimulated for 44 h at 37°C in 5% CO 2 , at which point the cells were pulsed with 0.5 Ci/well 
Analysis of apoptosis
Flow cytometry analysis of annexin V binding to phosphatidylserine on the cell surface. Cells to be examined for annexin V expression were washed in PBS and incubated with annexin V-biotin conjugate, in defined calcium and magnesium concentrations, according to the manufacturer's instructions (Boehringer Mannheim, Lewes, East Sussex, U.K.). The cells were washed and then incubated with streptavidin-FITC for 15 min and washed by centrifugation. Cells were immediately analyzed using a Becton Dickinson FACScan using Lysis II software (Becton Dickinson, Mountain View, CA) for analysis (27) .
Flow cytometry analysis of DNA content and cell cycle analysis. Cells were analyzed for propidium iodide (PI) incorporation as described previously (27, 28) . At least 10 4 stained cells were analyzed for PI fluorescence at an excitation wavelength of 488 nm on a Coulter Epics XL flow cytometer (Coulter, Luton, U.K.).
Flow cytometry analysis of mitochondrial potential. Incorporation of the cationic lipophilic dye DiOC 6 into the mitochondria is proportional to the mitochondrial transmembrane potential (⌬ m ) (29) . Cells were incubated for 30 min with 50 nM DiOC 6 (3) (Molecular Probes, Eugene, OR) and then washed once in PBS. At least 10 4 stained cells were analyzed using a Becton Dickinson FACScan using Lysis II software for analysis.
Qualitative analysis of internucleosomal DNA fragmentation by agarose gel electrophoresis. Fragmented DNA released from the nuclei of cells undergoing apoptosis was analyzed by ethidium bromide staining of DNA ladders resolved by agarose gel electrophoresis, as described previously (28) .
ATP determinations
ATP levels were measured using a commercial luciferase kit, ViaLight HS (Lumitech, Nottingham, U.K.), and a TD-20e luminometer (Turner, Mountain View, CA).
Cell stimulation and lysate preparation
WEHI-231 cells (10 7 cells) were stimulated as indicated, reactions terminated by the addition of 2ϫ ice-cold lysis buffer (50 mM Tris (pH 7.4), 150 mM sodium chloride, 2% (v/v) Nonidet P-40, 0.25% (w/v) sodium deoxycholate, 1 mM EGTA, 10 mM sodium orthovanadate, 0.5 mM PMSF, chymostatin (10 g/ml), leupeptin (10 g/ml), antipain (10 g/ml), and pepstatin A (10 g/ml)), and lysates solubilized for 30 min on ice before centrifugation at 12,000 rpm for 15 min. The resulting supernatants were used for Western blot analysis (26) .
Preparation of mitochondria-free extracts
Mitochondria-free extracts were prepared as described previously (30) . Briefly, 10 7 cells were washed in PBS and resuspended in extraction buffer (50 mM PIPES-KOH (pH 7.4), 50 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 220 mM mannitol, 68 mM sucrose, 1 mM DTT, 10 M cytochalasin B, and protease inhibitors). Cells were left on ice for 30 min and then lysed with a glass homogenizer, with 40 strokes of the B pestle. Finally, cells were centrifuged at 14,000 ϫ g for 15 min, and the mitochondria-free supernatant and mitochondrial pellets were taken for Western blot analysis of cytochrome c release. For isolated mitochondria, mitochondrial pellets were resuspended in mitochondria physiological buffer (MPB) comprising 20 mM HEPES containing 250 mM sucrose, 1 mM EGTA, 5 mM succinate, 3 mM KH 2 PO 4 , 1.5 mM MgCl 2 , 10 mM KCl, and 3 M Rotenone.
Western blotting
Protein lysates (100 g/well; Pierce MicroBCA protein assay (Rockford, IL)) were resolved by SDS-PAGE (12%) before electrotransfer onto polyvinylidene difluoride (Millipore, Watford, U.K.). Nonspecific binding was blocked at room temperature with 10% nonfat dried milk in PBS/Tween 20 (0.1%) under constant agitation. The primary Ab was incubated with the blot for at least 1 h at room temperature before addition of the appropriate alkaline phosphatase-conjugated secondary Ab (Sigma, St. Louis, MO) in 5% nonfat dried milk for 1 h with constant agitation. The blots were developed with enhanced chemifluorescence substrate (Amersham Life Sciences) or ImmunoStar reagent (Bio-Rad, Hercules, CA) and exposed to film. Prestained molecular weight markers were used to elucidate the molecular weight of unknown proteins. Even protein loading/sample recovery of gels was determined by Ponceau Red (Sigma) staining (26) .
RT-PCR
Cells (5-10 ϫ 10 6 /sample) were treated as required, then RNA was extracted using RNAzol B (Biogenesis, Bournemouth, U.K.), and reverse transcription of total RNA (5 g) was performed using SuperScript II RT and priming with random hexamers (Life Technologies, Paisley, U.K.) for 50 min at 42°C. Reactions were terminated by heating for 15 min at 70°C. PCR was performed in a total volume of 50 l containing 1 l of the RT reaction mixture, 0.2 mM dNTPs, 0.35 M of each primer, and 1 U of Taq polymerase (Sigma) in a Techne Cyclogene thermal cycler using the following primers for cPLA 2 : left primer, 5Ј-AAATGTCAGCCACAAC CCTC-3Ј and right primer, 5Ј-GGAGACACGTGAAGAGAGGC-3Ј (PCR product of 227 bp) for a total of 32 cycles using the following protocol: (94°C, 5 min) ϫ 1, (94°C, 30 s/56°C, 1 min/72°C, 1 min) ϫ 2, (94°C, 30 s/60°C, 1 min/72°C, 1 min) ϫ 30, (72°C, 5 min) ϫ 1. Primers specific for murine ␤-actin were used as a control: left primer, 5Ј-GGGCTAT GCTCTCCCTCACGCCATCCTGCG-3Ј and right primer, 5Ј-TTG GCATAGAGGTCTTTACGGATGTCAACG-3Ј (PCR product of 389 bp). The PCR products were then resolved by DNA-agarose (1.5%) gel electrophoresis.
cPLA 2 assay cPLA 2 activity in whole cell lysates or mitochondrial fractions was determined using a commercial cPLA 2 assay kit (Cayman Chemical, Ann Arbor, MI) based on spectrophotometric detection (A 414 ) of free thiol by Ellman's reagent (5,5Ј-dithio-bis(2-nitrobenzoic acid) following hydrolysis of the arachidonyl thioester bond at the sn-2 position of the cPLA 2 substrate, arachidonyl thio-phosphatidylcholine. A role for calcium-independent phospholipase A 2 (iPLA 2 ) activity was excluded by the use of the selective inhibitor bromoenol lactone and the requirement for calcium for PLA 2 activity.
In addition, in some experiments, cPLA 2 activity was assessed by measurement of [ 3 H]arachidonic acid release, as described previously (26) . This activity was blocked by the inhibitor arachidonyl trifluoromethyl ketone (selective for iPLA 2 and cPLA 2 ), excluding a role for secretory phospholipase A 2 . Briefly, before each experiment, cells were washed, resuspended in fresh isotope-free medium, and cultured for an additional hour at 37°C. The cells were then washed three times in HBSS (pH 7.4) containing 2% (w/v) BSA and 10 mM glucose, resuspended in this buffer at 10 7 cells/ml, and equilibrated for 30 min at 37°C. Cells (10 6 /assay) were then stimulated with the appropriate agent for the indicated time at 37°C. Reactions were terminated by the addition of 1 ml of ice-cold methanol/15 l of glacial acetic acid, followed by an additional 0.5 ml of methanol and 0.75 ml of chloroform, and the cells were extracted for 30 min on ice. Phases were split by the addition of choloroform and water, and the chloroform phase was then dried under vacuum. For measurement of [
3 H]arachidonate levels, 30-l samples (prepared in chloroform:methanol (2:1)) were spotted onto Silica Gel 60 thin layer plates and developed in hexane: diethylether:formic acid (80:20:2, by volume). After exposure to iodine vapor, arachidonate was identified by comparison with standards, the plate was sprayed lightly with water, and the corresponding silica gel was scraped from the plate and assayed for radioactivity.
In situ immunofluorescence analysis of intact cells
Following stimulation with either anti-Ig (10 g/ml) or ceramide (25 M) for 3 or 24 h, WEHI-231 B cells were washed and fixed (5 min) in PBS (pH 7.4) containing 4% (w/v) paraformaldehyde. The cells were then washed in PBS and permeabilized (5 min) in PBS containing 2% FCS, 2 mM EDTA, and 0.1% (w/v) saponin before incubation with the appropriate primary Abs (1 g) for 30 min at 4°C. The cells were washed again before staining with the relevant FITC-conjugated or biotinylated secondary Ab. Following further washing, the cells were stained simultaneously with streptavidin-Texas Red (Vector Laboratories, Burlingame, CA), 4Ј,6Ј-diamidino-2-phenylindole (Vector Laboratories), and, in some experiments, the mitochondrial-selelective dye rhodamine 123 (500 nM; Molecular Probes, Eugene, OR). In some experiments, the mitochondria were identified by staining with an anti-adenine dinucleotide transporter Ab (a kind gift from P. Schmid, Hormel Institute, University of Minnesota, Austin, MN). In situ immunofluorescence microscopy was performed using an Axioskop microscope (Zeiss, Oberkochen, Germany), charge-coupled device camera, and digital capture program (SignalAnalytics, IP Lab, Vienna, Austria).
Protease activity assays
WEHI-231 cells (5 ϫ 10 6 cells/sample) were stimulated with anti-Ig (10 g/ml) or ceramide (25 M) for 2, 5, 8, or 24 h at 37°C before cell lysates were prepared in 50 mM Tris buffer (pH 7.4) containing 150 mM sodium chloride, 2% (v/v) Nonidet P-40, 0.25% (w/v) sodium deoxycholate, 1 mM EGTA, 10 mM sodium orthovanadate, and 0.5 mM PMSF. Samples were then incubated for 30 min at room temperature with 100 M of either cathepsin B substrate, z-Arg-Arg-pNA (zRR-pNA; Calbiochem), or caspase-3 substrate, N-Acetyl-Asp-Glu-Val-Asp-pNA (Ac-DEVD-pNA; Calbiochem), and the resultant generation of cleaved substrate was measured by reading absorbance at 405 nm (31, 32) .
Results
Ligation of the Ag receptors on the immature B cell line, WEHI-231, induces growth arrest and apoptosis
Cross-linking of the Ag receptors with anti-Ig leads to a concentration-dependent induction of growth arrest and apoptosis in the B cell lymphoma, WEHI-231 ( Fig. 1) , which is a widely used model system for investigating the signaling mechanisms underlying 
IgD
Ϫ immature B cells. Growth arrest was assessed by the anti-Ig-mediated suppression of DNA synthesis in WEHI-231 B cells (Fig. 1A) , which showed that maximal growth inhibition was essentially achieved at concentrations of anti-Ig between 0.1 and 1 g/ml. This growth arrest was confirmed by cell cycle analysis, which showed the anti-Ig-driven accumulation of WEHI-231 cells in the G 0 -G 1 phase of the cell cycle (70 Ϯ 7% of stimulated live cells vs 47 Ϯ 10% for control live WEHI-231 cells 24 h poststimulation with anti-Ig (1 g/ml), n ϭ 4 independent experiments). Commitment to apoptosis was assessed by examining the anti-Ig-mediated disruption of mitochondrial membrane potential (as indicated by a decrease in the fluorescence of the mitochondrial dye, DiOC 6 ; Fig. 1B) , expression of phosphatidylserine (annexin V binding, Fig. 1C ) at the cell surface, DNA laddering (Fig. 1D) , and PI staining of hypoploidy DNA content during cell cycle analysis (Fig.  1C) . These studies showed that commitment to apoptosis required higher concentrations of anti-Ig (1-10 g/ml; Fig. 1D and results not shown) than those needed for induction of growth arrest following cross-linking of the Ag receptors.
Disruption of the inner mitochondrial potential (⌬ m ) plays a key role in Ag receptor-driven apoptosis of WEHI-231 cells: signals that rescue WEHI-231 B cells from apoptosis stabilize ⌬ m
Disruption of mitochondrial function and integrity has been shown to play a central role not only in the commitment to apoptosis, but also in the initiation of the execution of the later stages of apoptosis in many cell systems (12) (13) (14) .We therefore investigated the role of mitochondrial disruption in Ag receptor-driven apoptosis by characterizing the effects of anti-Ig on the ⌬ m . To do this quantitatively, we analyzed the incorporation of the cationic lipophilic dye DiOC 6 (3) into WEHI-231 B cells, as the uptake of this dye into mitochondria is directly proportional to ⌬ m (29) . Cross-linking of the Ag receptors on WEHI-231 immature B cells induced an early (within 5 h) substantial decrease in ⌬ m , followed by a profound dissipation of ⌬ m , which was maximal by 20 -24 h (Figs. 1B and 2, A and B) . In contrast, mature splenic B cells, which proliferate rather than apoptose following cross-linking of their Ag receptors (Fig. 2C) , do not exhibit this decrease in ⌬ m at either 3 or 24 h. Thus, the mitochondrial depolarization observed in WEHI-231 cells following cross-linking of the Ag receptors correlates with the commitment and induction of apoptosis.
The importance of ⌬ m stabilization to the survival of WEHI-231 immature B cells is further supported by the finding that costimulation via CD40, which has been widely shown to rescue Ag receptor-driven apoptosis (nuclear DNA loss; Fig. 3A) and growth arrest in G 0 -G 1 (Fig. 3B) , acts to stabilize ⌬ m (albeit at an intermediate ⌬ m ) and prevent the profound dissipation of ⌬ m observed in anti-Ig-treated cells (Fig. 2, A and B) . Furthermore, the mitochondrial inhibitors, antimycin (an inhibitor of respiratory chain complex III that blocks the transfer of electrons to cytochrome c, and hence suppresses respiration by blocking proton pumping, ATP synthesis, and oxygen uptake) and oligomycin (an inhibitor of respiratory chain complex V, the F 0 F 1 -ATPase: oligomycin inhibits proton transport back into the mitochondria by blocking the proton channel, F 0 protein), which can be used to stabilize the mitochondrial potential (33), maintain ATP levels (34) , and protect against apoptosis (35) , are not only capable of maintaining almost normal ⌬ m levels even in the presence of anti-Ig (Fig. 2D) , but are also able to protect against the surface Ig (sIg)-driven commitment of WEHI-231 immature B cells to apoptosis (nuclear DNA loss; Fig. 3A) . Like CD40 signaling, the mitochondrial inhibitor antimycin, and oligomycin to a very much lesser extent, is also able to prevent anti-Ig-mediated arrest in G 0 -G 1 , as indicated by its ability to protect entry into S phase (Fig.  3B) . However, unlike the CD40 rescue signals, they are unable to allow cell cycle progression through G 2 -M (Fig. 3B) . Together, these data suggest that mitochondrial function not only plays a central role in the commitment to death signaling in B cells, but also in the reversible induction of growth arrest by anti-IgM (36) .
Ag receptor-mediated disruption of the mitochondrial potential results in cellular ATP depletion and is associated with induction of mitochondrial PLA 2 activity
Loss of mitochondrial function and integrity has been shown to contribute to the effector stages of apoptosis via production of ROS, ATP depletion, calcium cycling, and release of cytochrome -axis) . The concentration of stimuli and mitochondrial inhibitors used was: anti-IgM, for WEHI-231 cells 10 g/ml, for splenic B cells 50 g/ml; anti-CD40, 10 g/ml; antimycin, 50 ng/ml; and oligomycin, 8 ng/ml. All data are from single experiments representative of at least two other independent experiments.
c, caspases, and apoptosis-inducing factors. Since our data clearly showed disruption of mitochondrial function, we investigated the potential downstream effector mechanisms involved in the execution of Ag receptor-driven apoptosis of WEHI-231 immature B cells. First, we investigated the role of ATP depletion in Ag-driven apoptosis of WEHI-231 cells: cross-linking of the Ag receptors induces a profound depletion of cellular ATP (Fig. 4A) . The kinetics of ATP depletion, which showed a lag before onset (5-10 h), are consistent with ATP depletion resulting from mitochondrial disruption. Moreover, as ATP depletion was apparent before the appearance of DNA ladders (Ն16 h), this depletion did not simply reflect cell necrosis resulting from apoptosis. Importantly, such ATP depletion and apoptosis could be blocked not only by the CD40 rescue signal, but also by the mitochondrial inhibitors, antimycin and oligomycin (Fig. 4, A and B) . Taken together, these results suggest that ATP depletion resulting from mitochondrial disruption plays a key role in Ag receptor-driven apoptosis of WEHI-231 immature B cells.
Generation of unsaturated fatty acids, such as arachidonic acid, by a mitochondrial PLA 2 activity has been reported to alter the permeability of the mitochondrial inner membrane resulting in the collapse of ⌬ m (15, (37) (38) (39) . Interestingly, we have recently shown (26) that cPLA 2 is only expressed and coupled to the Ag receptors on B cells under conditions of apoptotic signaling. Indeed, whereas apoptotic signaling via sIg strongly stimulates cPLA 2 , and growth-promoting signals via IL-4R or CD40 are not coupled to this activity (26), rescue from sIg-mediated apotosis by costimulation via CD40 uncouples sIg from cPLA 2 signaling in WEHI-231 immature B cells (Fig. 5A) . Moreover, consistent with a role for cPLA 2 in sIg-mediated apoptosis, addition of exogeneous arachidonic acid induces a dose-dependent state of profound growth arrest (26) and apoptosis, as indicated by DNA laddering (Fig. 5B) and induction of loss of nuclear DNA content (Fig. 5C ) in WEHI-231 immature B cells. We therefore investigated whether cPLA 2 played a role in the sIg-mediated collapse of ⌬ m and ATP depletion by determining whether signaling via sIg induced mitochondria-associated cPLA 2 activity under conditions that correlated with the collapse of ⌬ m , ATP depletion, and commitment to apoptosis: anti-Ig not only stimulated total cellular PLA 2 activity under apoptotic conditions, but some 20 -25% of this activity was found in purified isolated mitochondrial preparations (Fig. 5D) . The sIg-coupled PLA 2 activity is 1) calcium-dependent, 2) blocked by the cPLA 2 /iPLA 2 -selective inhibitor, arachidonyl trifluoromethyl ketone, and 3) not inhibited by the iPLA 2 -selective inhibitor, bromoenol lactone, ruling out a role for either iPLA 2 or secretory phospholipase A 2 in such arachidonic acid generation (results not shown). In addition, in situ immunofluorescence analysis of permeabilized cells indicates that cPLA 2 translocates to the mitochondria and the nucleus within 3 h of stimulation of WEHI-231 B cells via the B cell receptor (BCR), and this is at least partially reversed/ prevented by costimulation via CD40 (results not shown). Moreover, addition of exogeneous arachidonic acid elicited ⌬ m collapse in a manner analogous to that observed with anti-Ig (Fig.  5C) . Furthermore, although anti-Ig treatment was found to up-regulate cPLA 2 mRNA ( Fig. 6A ; 24 h) and protein ( Fig. 6B; 2 .25-fold basal levels at 48 h) levels, costimulation with anti-CD40 was found to prevent/reverse this up-regulation (Fig. 6, A and B ; 0.65-fold basal levels of cPLA 2 protein at 48 h). Taken together, these results suggest that sIg-mediated induction of mitochondrial cPLA 2 activation may play a key role in the collapse of ⌬ m and commitment to apoptosis in WEHI-231 immature B cells.
Ag receptor-mediated disruption of the mitochondrial membrane potential is not associated with cytochrome c release from the mitochondria or activation of caspase-3
To determine whether the observed Ag receptor-driven mitochondrial disruption also results in caspase-dependent execution of apoptosis of WEHI-231 immature B cells, we investigated whether the loss of mitochondrial potential correlated with activation of effector caspases as evidenced by release of cytochrome c from the mitochondria and cleavage of the caspase-3 substrates, PARP and Bcl-x L (40, 41) . Examination of mitochondria-free extracts showed that Ag receptor-mediated stimulation of WEHI-231 immature B cells failed to induce any release of cytochrome c into the cytosol over the 48-h time course of apoptosis measurements (Fig.  6C) , results consistent with a recent report that BCR-mediated apoptosis in WEHI-231 cells is independent of cytochrome c translocation from the mitochondria (42) . In contrast, cytochrome c release to such cytosolic fractions was easily detectable within 4 h following treatment of Jurkat cells with anti-Fas Abs. Moreover, in situ immunofluorescence analysis of intact cells showed that while cytochrome c remained localized to the mitochondria following stimulation of WEHI-231 cells with anti-Ig, cytochrome c release to the cytosol could be strongly detected (data not shown) following stimulation with the cell-permeant sphingolipid, C 2 -ceramide (25 M), which can induce apoptosis of WEHI-231 B cells via the classical caspase-dependent route (43) .
Similarly, although there appears to be a very low level of constitutive caspase activity in untreated WEHI-231 cells, resulting in the generation of low levels of the cleaved form of PARP, no stimulation of caspase-3 activity, as evidenced by the lack of stimulated cleavage of PARP (Fig. 6, D and E) or Bcl-x L (data not shown), was observed following stimulation (for up to 48 h) of these immature B cells via the Ag receptors. In contrast, PARP cleavage was easily detectable within 24 h following culture with C 2 -ceramide (25 M; Fig. 6E ). These results were again confirmed by in situ immunofluorescence analysis, which showed the presence of cleaved PARP fragments in intact cells stimulated with C 2 -ceramide, but not anti-Ig (results not shown). Interestingly, and consistent with sIg-mediated induction of mitochondrial PLA 2 activation playing a key role in anti-Ig-stimulated apoptosis of WEHI-231 immature B cells, we find that while addition of exogeneous arachidonic acid (25 M) induces apoptosis (Fig. 5, B and  C) , it does not stimulate activation of caspase 3 and resultant PARP cleavage in these cells (Fig. 6E) .
Caspase inhibitors do not relieve Ag receptor-mediated growth arrest or apoptosis in WEHI-231 immature B cells
The failure of anti-Ig to induce a PARP-cleaving caspase activity or the release of cytochrome c from the mitochondria of WEHI-231 immature B cells suggested that Ag receptor-driven apoptosis of these cells may occur in a caspase-independent manner. To investigate this possibility further, we examined the effect of caspase inhibitors on the Ag receptor-driven growth arrest and apoptosis of WEHI-231 immature B cells. To control for the efficacy of these reagents, we conducted parallel experiments demonstrating their ability to protect against the caspase-dependent growth arrest and programmed cell death of Jurkat T cells resulting from stimulation via the Ag receptors (anti-CD3 or PHA), TNF-␣, or Fas death receptors to determine whether the Ag receptors on WEHI-231 immature B cells (BCR) and Jurkat T cells (TCR-CD3 complex) utilized different apoptosis pathways.
The role of individual caspase subtypes in these models of lymphocyte apoptosis was assessed by the use of selective caspase inhibitors: while z-VAD-fmk is considered to be a pan-caspase inhibitor (44) with a high affinity for the caspase-1-like subfamily and a lower affinity for the caspase-3-like subfamily (45), Ac-DEVD-CHO shows greater affinity for caspase-3 than for the caspases-1, -4, and -7, and z-VEID-fmk is a potent caspase-6 inhibitor that has little effect on caspase-3, -4, -7, and -8 (46). We found that z-VAD-fmk was able to completely reverse Fas-mediated growth arrest and partially overcome anti-CD3 and, to a lesser extent, TNF-␣ -induced growth arrest (Fig. 7A , and results not shown), findings consistent with previously published studies (40) . However, Ac-DEVD-CHO and z-VEID-fmk were unable to rescue either Fas-or TNF-mediated growth arrest (Fig. 7A, and results not  shown) . Nevertheless, and in agreement with previous studies (47, 48) , all three inhibitors, albeit to a lesser extent, z-VEID-fmk, were able to prevent Fas-mediated apoptosis of Jurkat T cells (Fig. 7A) .
In contrast, none of these inhibitors had any effect on anti-Igmediated growth arrest, annexin V binding, cell cycle progression, or nuclear DNA loss (subdiploid cells) of WEHI-231 immature B cells (Figs. 7, B-D, and 8 , A-C, and results not shown). However, z-VAD-fmk (1 nM to 10 M, maximal 1 nM), Ac-DEVD-CHO (maximal Ͼ100 pM), and z-VEID-fmk (Ն10 M) were able to partially block C 2 -ceramide induction of nuclear DNA loss (but not growth arrest, Fig. 7 , B-D) in WEHI-231 B cells (Fig. 8, A and B, and results not shown), and both z-VAD-fmk and Ac-DEVD-CHO were able to inhibit apoptosis of germinal center (peanut agglutinin (PNA) ϩ ) B cells (Fig. 8D) , results demonstrating the efficacy of these inhibitors in our B cell systems. In addition, while treatment of WEHI-231 cells with C 2 -ceramide can induce activation of a caspase-3-like activity, which can be blocked by the caspase-3 inhibitor, Ac-DEVD-CHO, cross-linking of the BCR for up to 24 h (2, 5, 8, and 24 h) does not induce activation of this caspase (Fig. 8E, and results not shown) .
In direct contrast, the cathespsin B inhibitor, EST (24), strongly inhibits sIg-mediated apoptosis of WEHI-231 B cells (as indicated by loss of nuclear DNA content, Fig. 9A ). In addition, although cross-linking of the BCR does not induce activation of capase-3 activity, it does stimulate the cleavage of the cathepsin B substrate zRR-pNA (Fig. 9B) . Moreover, although inhibition of sIg-mediated apoptosis by EST was maximal by 1 nM, the percentage of subdiploid cells resulting from stimulation with C 2 -ceramide was not reduced by this reagent at concentrations of EST Յ 10 M (Fig. 9A) , providing further evidence that anti-Ig and C 2 -ceramide stimulate apoptosis of WEHI-231 cells by distinct mechanisms. Despite preventing BCR-driven apoptosis, EST did not block anti- Ig-stimulated growth arrest (Fig. 9C) , nor did it prevent anti-Igdriven collapse of ⌬ m (Fig. 9D) . In contrast, z-VAD (1 nM-100 M) was able to block C 2 -ceramide, but not anti-Ig-mediated disruption of ⌬ m in WEHI-231 cells. Taken together, these results suggest that the execution phase of BCR-driven apoptosis is mediated by cathepsin B (or similar proteases) rather than by effector caspases.
Discussion
Commitment to Ag receptor-driven apoptosis of the B cell lymphoma, WEHI-231, correlates with mitochondrial PLA 2 activation, leading to disruption of mitochondrial function and ATP depletion. Rather surprisingly, however, such apoptosis is executed independently of caspase activation and instead, the executioner phase appears to involve the BCR-driven, postmitochondrial activation of the protease, cathepsin B. This novel mechanism of B cell apoptosis is supported by several lines of evidence: first, we demonstrate a pivotal role for mitochondrial function in determining commitment to B cell survival or apoptosis by showing that cPLA 2 expression and mitochondrial activity are up-regulated under conditions of sIg-driven apoptosis and down-regulated during CD40-mediated rescue (Figs. 5  and 6 ). Second, the ⌬ m is disrupted, resulting in depletion of cellular ATP under conditions of apoptotic, but not proliferative, signaling via the BCR (Figs. 1-4) . Importantly, such collapse of ⌬ m can be mimicked by addition of exogeneous arachidonic acid, while disruption of ⌬ m , ATP depletion, and apoptosis can be blocked by rescue signals via CD40 or by ⌬ m stabilizers such as antimycin or oligomycin (Figs. 2-4) . Third, we show that activation of caspases is not essential for commitment and postmitochondrial execution of BCR-mediated apoptosis by demonstrating that apoptotic signaling via the BCR or following addition of exogeneous arachidonic acid does not induce either the release of cytochrome c from mitochondria, which is required for the activation of the caspase-3 cascade (49, 50) , nor does it cause cleavage of PARP (Fig. 6) or Bcl-x L (results not shown), which have been reported to be suitable markers of caspase-3-like effector activity in various cell types (40, 41) . Indeed, apoptotic signaling via the BCR in WEHI-231 B cells does not appear to stimulate the activation of caspase-3 (Fig. 8) . Consistent with this, BCR-mediated disruption of ⌬ m and commitment to apoptosis take place in the presence of caspase inhibitors (Figs. 7-9 ), indicating that none of the known initiator or effector caspases are essential for the commitment or execution of BCR-induced apoptosis of WEHI-231 immature B cells. Rather, apoptotic signaling via the BCR stimulates the postmitochondrial activation of the protease, cathepsin B (Fig. 9 ), which has previously been shown to be a key executioner protease in alternative mechanisms of apoptosis that have recently been described (51) . That this PLA 2 -dependent mechanism of mitochondrial function is likely to be a key checkpoint of Ag-driven cell fate is evidenced by the downregulation of PLA 2 activation and expression, and protection of mitochondrial function, resulting from signaling via CD40, which effects rescue from BCR-mediated apoptosis in these WEHI-231 immature B cells.
ATP depletion resulting from oxidant-induced calcium release from mitochondria followed by excessive calcium cycling and collapse of ⌬ m has been proposed to be a hallmark of apoptosis (15) . Interestingly, production of ROS has previously been shown to increase following apoptotic signaling via sIg on WEHI-231 immature B cells (52) . Moreover, CD40 signaling, which rescues these cells from apoptosis, leads to an increase in the expression of Bcl-x L (53, and our unpublished observations), which prevents accumulation of intracellular oxidants (52, 53) , blocks thapsigargin-induced intracellular mobilization of calcium from the endoplasmic reticulum (54) , and stabilizes ⌬ m and mitochondrial homeostasis (22) . However, our findings that the mitochondrial inhibitors, antimycin and oligomycin, which will induce the production of ROS (55), protect against sIg-mediated ATP depletion and apotosis (Fig. 3) , together with our observed lack of effect of ROS inhibitors on BCR-mediated growth arrest and apoptosis of WEHI-231 cells (results not shown), argue against a role for ROS in BCR-driven collapse of ⌬ m in WEHI-231 B cells. Consistent with this, it has recently been shown that rather than induce apoptosis, low levels of ROS appear to exert mitogenic or antiapoptotic effects (56, 57) .
An alternative candidate apoptotic pathway for the collapse of ⌬ m and ATP depletion involves the stimulation of mitochondrial PLA 2 activity, resulting in the accumulation of unsaturated fatty acids (arachidonic acid) that have been reported to alter the permeability of the mitochondrial inner membrane, resulting in the collapse of ⌬ m (15, (37) (38) (39) . Indeed, we have found that whereas apoptotic signaling via sIg up-regulates cPLA 2 expression, induces its translocation to the mitochondria, and strongly stimulates cPLA 2 activity (Figs. 5 and 6, and results not shown), rescue from BCR-mediated apotosis by costimulation via CD40 down-regulates cPLA 2 expression and uncouples sIg from cPLA 2 translocation and signaling in WEHI-231 immature B cells (Figs. 5 and 6 , and results not shown). In addition, and consistent with a role for cPLA 2 in this sIg-mediated, mitochondrial-dependent mechanism of apoptosis, addition of exogeneous arachidonic acid induces a profound collapse of ⌬ m and resultant induction of growth arrest (26) and apoptosis ( Fig. 5 ) in WEHI-231 immature B cells. That arachidonic acid is the active lipid moiety is supported by our preliminary findings that while cyclooxygenase inhibitors promote BCR-mediated apoptosis, signaling via CD40 acts to promote intracellular PGE 2 production (our unpublished results). Taken together, these results suggest that sIg-mediated induction of mitochondrial PLA 2 and generation of arachidonic acid may play a key role in the collapse of ⌬ m and commitment to apoptosis in WEHI-231 immature B cells. The mechanisms downstream of mitochondrial membrane depolarization and ATP depletion have not, as yet, been delineated, but the failure of anti-Ig to induce a PARP-cleaving caspase activity or the release of cytochrome c from the mitochondria of WEHI-231 immature B cells (Fig. 6) suggested that BCR-driven apoptosis of these cells is not dependent on caspase activation, a proposal supported by our findings that signaling via sIg does not induce caspase-3 activation and that caspase inhibitors did not prevent BCR-mediated growth arrest and apoptosis in such cells (Fig.  8) . At first sight, therefore, these results appear to conflict with previously published reports that showed that sIg was coupled to the activation of caspases and that such caspase activation played a role in sIg-mediated apoptosis of WEHI-231 (43, 58) and primary immature B cells (59) . However, by using z-VAD-fmk at high concentrations (Ն100 M), we have been able to reproduce some of the effects of caspase inhibitors on sIg-mediated apoptosis presented in the earlier papers: these apparent differences may therefore simply reflect the use of high concentrations (Ն12.5 M) of caspase inhibitors in the earlier studies, as it is now widely recognized that at concentrations Ͼ10 M, z-VAD-fmk will inhibit other cysteine proteases such as calpain and cathepsin B (51) . Consistent with this, we find that apoptotic signaling via the BCR stimulates cathepsin B activity (Fig. 9) and that the postmitochondrial stages of Ag receptor-driven apoptosis in WEHI-231 immature B cells are blocked by the cathepsin B inhibitor EST (Fig. 9) . Similarly, BCR-mediated apoptosis can also be prevented by the serine and cysteine protease-selective, caspase-independent inhibitor, N␣-( p-tosyl)lysine chloromethyl ketone (46, 60) , and partially by the calpain and/or cathepsin-selective inhibitors, leupeptin, antipain, and pepstatin (results not shown) (60 -62) . Interestingly, recent evidence now suggests that ATP depletion can lead to the induction of DNA fragmentation and consequent apoptosis in a caspase-independent, but N␣-( p-tosyl)lysine chloromethyl ketone-or 1-1-tosylamido-2-phenyethyl chloromethyl ketone-sensitive, protease-dependent manner (63) . Taken together, these findings suggest that, in addition to an inability to drive the energetically unfavorable reactions involved in the metabolic, biosynthetic, and signal transduction processes required for cell survival and cell cycle progression (12, 14, 56, 64, 65) , ATP depletion can trigger the postmitochondrial activation of a cathepsin-B-like protease-dependent mechanism of DNA fragmentation and apoptosis in WEHI-231 B cells stimulated via the BCR.
Finally, our results show that caspase inhibitors can block sIgmediated apoptosis of germinal center (PNA ϩ ) B cells, suggesting that B cells may employ distinct maturation stage-specific mechanisms of apoptosis. However, this rescue by caspase inhibitors is only partial and may reflect the results of a recent study that show that apoptosis of human germinal center B cells requires the activation of both caspase and cathepsin activities, the cathepsin activity being downstream of caspase-3 and responsible for exonuclease activity and execution of apoptosis (24) . Taken together with caspase-dependent processes of apoptosis observed in Jurkat T cells, therefore, our results may suggest that there is a fundamental difference in the way that the Ag receptors on B and T cells signal commitment to growth arrest and apoptosis, and this proposal could reflect recent reports that while caspase-deficient mice exhibited aberrant T cell development, they did not appear to have significant defects in B cell selection and development (8, 9, 25) .
